• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3: New insider Mcandrew Jamie claimed ownership of 10,234 shares

    9/5/23 7:21:25 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $WINT alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    McAndrew Jamie

    (Last) (First) (Middle)
    2600 KELLY ROAD
    SUITE 100

    (Street)
    WARRINGTON PA 18976

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    08/24/2023
    3. Issuer Name and Ticker or Trading Symbol
    WINDTREE THERAPEUTICS INC /DE/ [ WINT ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    VP, Controller, & CAO
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 10,233 D
    Common Stock 1 I By Trust(1)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Employee Stock Option (Right to Buy) (2) 02/02/2026 Common Stock 1 6,990 D
    Employee Stock Option (Right to Buy) (2) 07/28/2026 Common Stock 2 5,310 D
    Employee Stock Option (Right to Buy) (2) 03/01/2027 Common Stock 5 3,690 D
    Employee Stock Option (Right to Buy) (2) 02/07/2029 Common Stock 200 592.5 D
    Employee Stock Option (Right to Buy) (2) 01/22/2031 Common Stock 400 272 D
    Employee Stock Option (Right to Buy) (3) 01/22/2031 Common Stock 220 272 D
    Employee Stock Option (Right to Buy) (4) 03/04/2032 Common Stock 372 51 D
    Employee Stock Option (Right to Buy) (5) 08/23/2033 Common Stock 15,000 1.21 D
    Explanation of Responses:
    1. Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
    2. The shares subject to this option are fully vested and exercisable.
    3. This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on January 22, 2022 provided that the reporting person remains in continuous service on each vesting date.
    4. This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the option on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date.
    5. This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
    Remarks:
    Exhibit List - Exhibit 24 - Power of Attorney
    /s/ Jamie McAndrew 09/05/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $WINT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WINT

    DatePrice TargetRatingAnalyst
    More analyst ratings